Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine
Phase 3
Recruiting
- Conditions
- Common Cold
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 177
- Registration Number
- NCT06531707
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain
Phase 3
Completed
- Conditions
- Acute Low-back Pain
- Interventions
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 190
- Registration Number
- NCT06517823
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain
Phase 3
Recruiting
- Conditions
- Chronic Low-back Pain
- Interventions
- Drug: Celecoxib+Pregabalin+Vitamin B fixed doseDrug: Pregabalin + Vitamin B fixed doseDrug: Celecoxib + Vitamin B fixed dose
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 192
- Registration Number
- NCT06516094
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05533073
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral Suspension
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05428293
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05428306
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Pregabalin 150mgDrug: Fixed dose combination Pregabalin 150 mg / Tramadol 50 mgDrug: Tramadol 50 mg
- First Posted Date
- 2022-05-25
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 30
- Registration Number
- NCT05389150
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin
Phase 3
Completed
- Conditions
- Neuropathic Pain
- Interventions
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 110
- Registration Number
- NCT05324059
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Ciudad de México, Mexico
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
Completed
- Conditions
- Seborrheic DermatitisPsoriasis of Scalp
- Interventions
- Other: Allantoin/ Coal Tar/ ClioquinolOther: Allantoin/ Coal Tar/ Clioquinol/ Triclosan
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 90
- Registration Number
- NCT05105139
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 36
- Registration Number
- NCT05090449
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
© Copyright 2025. All Rights Reserved by MedPath